Survival Strategies: The Life Sciences Industry Turns to eLearning

by Susan McLaughlin, Drug Information Association The Drug Information Association unveils the first in a series of professional development programs delivered through eLearning technologies to members worldwide.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

over 22 years ago

Article

Demonstrating the Consistency of Small Data Sets: Application of the Weisberg t-test for Outliers

over 22 years ago

Article

Sumeria to Satellites: Evolution of the Bioreactor

over 22 years ago

Article

Patent Law: Extracting Maximum Value from Your Patent Portfolio

over 22 years ago

Article

A Statistical Method to Account for Plate-to-Plate Variability in Multiple-Plate Bioassays

over 22 years ago

Article

Inside Washington: Medication Safety in the Limelight

over 22 years ago

Article

Part 11 Is Not Going Away: The New Electronic Records Draft Guidance

over 22 years ago

Article

Analytical Advances: Collaborative Effort Results in Automated Cell Culture System

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Survival Strategies: The Life Sciences Industry Turns to eLearning

Articles in this issue

Newsletter

Trending on BioPharm International

Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress

Analytics, Automation, and Quality Driving the Next Era of Drug Development

Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis